SFM

Sphera Funds Management Portfolio holdings

AUM $479M
1-Year Est. Return 66.44%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+66.44%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$479M
AUM Growth
+$56.9M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
128
New
Increased
Reduced
Closed

Top Buys

1
+$9.19M
2
+$8M
3
+$7.87M
4
VOR icon
Vor Biopharma
VOR
+$7.64M
5
ORIC icon
Oric Pharmaceuticals
ORIC
+$6.59M

Top Sells

1
+$19M
2
+$18.2M
3
+$13.8M
4
PRAX icon
Praxis Precision Medicines
PRAX
+$10.8M
5
TEVA icon
Teva Pharmaceuticals
TEVA
+$9.45M

Sector Composition

1 Healthcare 85.98%
2 Technology 11.47%
3 Industrials 1.25%
4 Communication Services 0%
5 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DAWN icon
76
Day One Biopharmaceuticals
DAWN
$2.22B
$1.35M 0.28%
145,371
-30,000
VYGR icon
77
Voyager Therapeutics
VYGR
$246M
$1.34M 0.28%
339,761
+140,000
TRDA icon
78
Entrada Therapeutics
TRDA
$536M
$1.14M 0.24%
+110,942
TNYA icon
79
Tenaya Therapeutics
TNYA
$170M
$1.07M 0.22%
+1,500,000
CATX icon
80
Perspective Therapeutics
CATX
$479M
$962K 0.2%
349,973
-160,370
BMY icon
81
Bristol-Myers Squibb
BMY
$123B
$944K 0.2%
17,500
JSPR icon
82
Jasper Therapeutics
JSPR
$28.6M
$888K 0.19%
485,401
-144,069
PEPG icon
83
PepGen
PEPG
$117M
$791K 0.17%
121,467
-50,000
STTK icon
84
Shattuck Labs
STTK
$569M
$713K 0.15%
+195,212
PALI icon
85
Palisade Bio
PALI
$402M
$433K 0.09%
+184,100
HOWL icon
86
Werewolf Therapeutics
HOWL
$46M
$397K 0.08%
626,810
SKYE icon
87
Skye Bioscience
SKYE
$26.3M
$359K 0.08%
478,928
PRLD icon
88
Prelude Therapeutics
PRLD
$280M
$356K 0.07%
+122,752
APRE icon
89
Aprea Therapeutics
APRE
$11.5M
$230K 0.05%
270,000
OKUR
90
OnKure Therapeutics
OKUR
$68.4M
$175K 0.04%
60,454
MREO
91
Mereo BioPharma
MREO
$53.7M
$106K 0.02%
+255,400
PMN icon
92
ProMIS Neurosciences
PMN
$103M
$80.6K 0.02%
11,807
APLT
93
DELISTED
Applied Therapeutics
APLT
$5K ﹤0.01%
50,000
AMZN icon
94
Amazon
AMZN
$2.69T
– –
-13,760
ARWR icon
95
Arrowhead Research
ARWR
$9.73B
– –
-12,496
BHVN icon
96
Biohaven
BHVN
$1.65B
– –
-91,155
CDTX
97
DELISTED
Cidara Therapeutics
CDTX
– –
-75,743
CEVA icon
98
CEVA Inc
CEVA
$650M
– –
-81,085
CLBT icon
99
Cellebrite
CLBT
$3.29B
– –
-298,948
CMMB
100
Chemomab Therapeutics
CMMB
$12M
– –
-179,425
2 3
4
5 6